PatternsRadar
Sign in

WINDLASWindlas Biotech Limited

NSE
961.25INR-21.20 (-2.16%)Close · 20 Nov 2026
5 Nov 2026Last results
HealthcareSector
Pharmaceuticals & BiotechnologyIndustry
₹1,984 CrMarket cap
29.8P/E (TTM)
57.6%Delivery

Filings & corporate actions

23 results filed
CSV
Next results · Q3 FY27
Expected 3 Feb 2027 – 11 Feb 2027
Estimate: filed 34–42 days after quarter end, last 5 times
Dividend
₹6.30 per share · last 16 Jul 2026
2026
  • 5 NovresultsResults · Q2 FY27 · standalone+7.9%NSE
  • 17 OctshareholdingShareholding · 30 Sept 2026-1.2%NSE
  • 10 AugresultsResults · Q1 FY27 · standalone+12.3%NSE
  • 16 JulshareholdingShareholding · 30 Jun 2026+1.2%NSE
  • 16 JuldividendDividend · ₹6.30 per share+1.2%
  • 14 JulresultsResults · Q4 FY26 · consolidated and standalone-1.3%NSE
  • 26 MayshareholdingShareholding · 18 May 2026+4.8%NSE
  • 21 MayresultsResults · Q4 FY26 · consolidated and standalone+1.0%NSE
  • 24 AprbuybackBuy Back-3.9%
  • 15 AprshareholdingShareholding · 31 Mar 2026+6.4%NSE
  • 5 FebresultsResults · Q3 FY26 · consolidated and standalone+2.0%NSE
  • 20 JanshareholdingShareholding · 31 Dec 2025-5.7%NSE

Reaction to results · all yearsrose on day 0 in 12 of 22 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY275 Nov 2026+7.9%+8.7%—23.4×
Q1 FY2710 Aug 2026+12.3%+9.3%+36.5%55.4×
Q4 FY2621 May 2026+1.0%+3.9%+9.6%4.6×
Q3 FY265 Feb 2026+2.0%-3.8%-12.6%2.0×
Q2 FY266 Nov 2025-5.7%-11.1%-16.6%9.2×
Q1 FY2612 Aug 2025+11.9%+7.0%+5.1%18.8×
Q4 FY2522 May 2025-5.5%-6.0%-8.9%8.4×
Q3 FY2511 Feb 2025+1.9%-19.8%+6.1%3.0×
Q2 FY2512 Nov 2024+1.8%-2.8%+5.4%1.3×
Q1 FY2513 Aug 2024-12.0%-6.5%+3.9%4.9×
Q4 FY2420 May 2024+9.9%+11.1%+26.5%17.1×
Q3 FY248 Feb 2024-2.5%-2.5%+7.0%2.1×
Q2 FY248 Nov 2023-0.8%+8.0%+8.6%1.3×
Q1 FY249 Aug 2023+5.2%+18.3%+12.8%3.0×
Q4 FY236 May 2023+3.3%+5.0%+9.3%5.1×
Q3 FY239 Feb 2023+3.4%+5.9%+4.5%3.7×
Q2 FY239 Nov 2022-0.1%-5.2%+1.7%3.5×
Q1 FY234 Aug 2022-1.8%-3.4%+7.6%1.4×
Q4 FY2212 May 2022+5.4%+5.9%+6.1%2.3×
Q3 FY223 Feb 2022-0.9%+7.7%-10.3%1.9×
Q2 FY222 Nov 2021-0.6%-1.9%-9.8%1.2×
Q1 FY228 Sept 2021-2.7%-2.9%-9.3%—
Average+1.5%+1.1%+4.0%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q4 FY26

Revenue YoY+18.7%
Profit YoY+1.4%
Interest cost YoY+38.6%
Revenue QoQ+6.4%
Profit QoQ+2.3%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+18.9%+20.8%————
Profit+4.4%+12.6%————

Key data

Open982.05
Day range949.55 – 985.95
52-week range697.40 – 1,181.90
From 52w high-18.7%
RSI (14)49.1
ATR (14)43.57
Volume33.3K
Avg volume (20D)1.45L
Rel volume0.23×
Volatility (1Y)38.2%
Turnover₹3.2Cr
Traded value (NSE)₹3.2Cr
VWAP969.23
SMA 50 / 200996.86 / 881.16
Price band20%

Delivery percentage

Latest · 20 Nov 202657.6%
20-day avg50.1%
1-year avg53.9%
Percentile (own history)66th
Range12.2–92.9%
Sessions1,302

Over the last 20 sessions WINDLAS settled 50.1% of its traded quantity, which is above average for an NSE equity. Its one-year average is 53.9%, so recent sessions are running 3.7 points lower than usual. The latest session ranks higher than 66% of the 1,302 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.66%
Dividend, trailing 12M₹6.30
Paid every year for5 yr
Shareholders—
Net bulk deals, 30D+0.73%
Block deals, 30D₹0
Last bulk buy14 days ago

Performance returns

1D1W1M3M6M1Y
Price-2.16%-4.01%+6.76%-2.73%+22.87%+17.13%

Valuation

Market cap₹1,984 Cr
Market cap (NSE)₹1,984 Cr
Free-float cap₹728 Cr
P/E (TTM)29.8
P/E (NSE)30.4
EPS (TTM)32.31
P/B3.5
Net margin (TTM)6.8%
Other income / PBT20.7%
ROE12.1%
Debt / equity0.08
Shares outstanding2.11Cr
Listed16 Aug 2021

Ownership

Promoter63.31%
Promoter Δ QoQ0.00 pp
Public36.69%
FII—
DII—
Pledged—

Quarterly results · consolidated

Q1 FY26Q2 FY26Q3 FY26Q4 FY26
Revenue (₹ Cr)210.1222.4233.1238.5
YoY chg+19.9%+18.9%+19.5%+17.7%
Net profit (₹ Cr)17.717.815.016.0
YoY chg+31.0%+13.7%-3.7%-1.8%
Net margin8.4%8.0%6.4%6.7%
EPS8.348.407.057.49

Shareholding over time

By quarter

30 Sept 2026 · promoter 63.31% · public 36.69%
30 Sept 2021: promoter 59.95%31 Dec 2021: promoter 59.95%31 Mar 2022: promoter 59.95%30 Jun 2022: promoter 59.95%30 Sept 2022: promoter 59.95%31 Dec 2022: promoter 60.75%15 Feb 2023: promoter 61.22%31 Mar 2023: promoter 62.38%10 Apr 2023: promoter 62.44%30 Jun 2023: promoter 62.82%30 Sept 2023: promoter 62.82%31 Dec 2023: promoter 62.82%31 Mar 2024: promoter 62.82%30 Jun 2024: promoter 62.51%30 Sept 2024: promoter 62.51%31 Dec 2024: promoter 62.51%31 Mar 2025: promoter 62.34%30 Jun 2025: promoter 62.34%30 Sept 2025: promoter 61.99%31 Dec 2025: promoter 61.99%31 Mar 2026: promoter 61.90%18 May 2026: promoter 63.31%30 Jun 2026: promoter 63.31%30 Sept 2026: promoter 63.31%
2021-092026-09
  • Promoter
  • Public and others
Promoter
63.31%
Public
36.69%
Promoter change
0.00 pp
Filed
17 Oct 2026
FII
—
DII
—
Promoter pledged
—

Who the public is

Mutual funds
—
Insurance
—
FPI
—
Retail ≤ ₹2L
—
HNI > ₹2L
—
NRI
—
Bodies corporate
—
Shareholders
—

Major holders

As of 30 Jun 2026
HolderTypeHolding
AKW WBL Family Private Trust (through its Trustees Ashok Vimla Trusteeship Services Private Limited)Promoter · Other40.61%
Ashok Kumar WindlassPromoter · Individual21.32%
Icici Prudential Pharma Healthcare And Diaganostics (P.H.D) FundMutual fund3.42%
Mncl Capital Compounder Fund 2AIF1.70%
Bandhan Small Cap FundMutual fund1.43%
Vimla WindlasssPromoter · Individual1.38%
Ajay Kumar AggarwalIndividual1.21%
Perpetuity Health To Wealth (H2w) Rising FundAIF1.11%
Hitesh WindlassPromoter · Individual0.00%
Manoj Kumar WindlassPromoter · Individual0.00%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 9 Sept 2022 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹6.30₹6.30
FY2025-261₹5.80₹5.80
FY2024-251₹5.50₹5.50
FY2023-241₹4.00₹4.00
FY2022-231₹3.50₹3.50
Ex-dateRecord dateDeclaredAdjusted
16 Jul 2026—₹6.30₹6.30
21 Jul 2025—₹5.80₹5.80
17 Sept 2024—₹5.50₹5.50
5 Sept 2023—₹4.00₹4.00
9 Sept 2022—₹3.50₹3.50

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

Bulk & block deals · 6 Nov 2026

CSV
12 of 25 deals
By year
DateDealClientQuantityPriceValue
6 Nov 2026Buy · bulkSTELLAR WEALTH PARTNERS INDIA FUND I LP1.50L1,020.42₹15.4Cr
11 Aug 2026Sell · bulkNK SECURITIES RESEARCH PRIVATE LIMITED1.19L936.43₹11.1Cr
11 Aug 2026Buy · bulkNK SECURITIES RESEARCH PRIVATE LIMITED1.19L935.99₹11.1Cr
20 Feb 2025Buy · bulkAJAY KUMAR AGGARWAL1.45L787.42₹11.4Cr
19 Feb 2025Sell · bulkSAMVITTI CAPITAL PRIVATE LIMITED ACTIVE ALPHA MULTICAP1.15L683.49₹7.9Cr
1 Mar 2024Buy · bulkGRAVITON RESEARCH CAPITAL LLP1.11L565.96₹6.3Cr
1 Mar 2024Sell · bulkGRAVITON RESEARCH CAPITAL LLP1.11L564.94₹6.3Cr
8 Feb 2024Buy · bulkGRAVITON RESEARCH CAPITAL LLP1.35L522.39₹7.1Cr
8 Feb 2024Sell · bulkGRAVITON RESEARCH CAPITAL LLP1.35L522.27₹7.1Cr
2 Jan 2024Sell · bulkGRAVITON RESEARCH CAPITAL LLP4.10L517.50₹21.2Cr
2 Jan 2024Buy · bulkGRAVITON RESEARCH CAPITAL LLP4.10L517.17₹21.2Cr
2 Jan 2024Buy · bulkJAINAM BROKING LIMITED1.50L511.50₹7.7Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares bought on broker margin funding (MTF) and still held at the day’s end, and the amount brokers have lent against them.

Exchange surveillance

20 Nov 2026

No surveillance measure applies to WINDLAS.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q1 FY24Q2 FY24Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26A
Revenue from operations144.8152.7162.2171.3175.2187.0195.0202.7210.1222.4233.1238.5
Other income2.63.23.24.44.14.84.14.95.23.64.64.4
Total income147.4155.9165.4175.7179.3191.8199.1207.6215.3226.0237.7242.8
Total expenses131.1137.6145.6153.1161.0171.6178.8186.8192.1202.5217.7222.7
└ Finance costs0.20.30.30.30.51.11.51.31.11.01.31.5
└ Depreciation3.23.33.43.56.26.56.98.37.47.67.78.0
Profit before tax16.318.319.822.618.320.320.320.823.323.620.020.2
Tax expense4.34.34.75.64.84.64.84.55.65.85.04.2
Net profit12.114.015.117.013.515.715.616.317.717.815.016.0
EPS5.796.757.268.176.477.497.457.778.438.487.127.58
Net margin8.33%9.19%9.31%9.92%7.70%8.37%7.99%8.03%8.41%8.00%6.44%6.70%
PBT margin11.29%11.99%12.21%13.21%10.45%10.85%10.43%10.27%11.07%10.61%8.57%8.45%
Tax rate26.16%23.38%23.77%24.92%26.39%22.81%23.41%21.81%24.05%24.54%24.88%20.69%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 21 May 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 H1 FY23FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26
Total assets518.2529.0570.0626.2746.9760.5814.2907.3
Current assets404.3353.5388.4431.3517.2525.1563.5626.9
└ Cash & equivalents21.93.71.25.30.40.40.20.5
└ Other bank balances78.621.826.325.731.115.514.81.3
└ Current investments78.9106.5141.2173.4181.6223.4245.6268.4
└ Trade receivables105.3116.9127.4136.3186.8166.9197.8227.4
└ Inventories82.274.761.162.282.081.470.361.8
Total equity408.3402.3416.2449.9471.2505.8534.1580.8
└ Attributable to owners408.3402.3416.2449.9471.2505.8534.1580.8
└ Non-controlling interest———0.0——0.0—
└ Share capital10.910.510.410.410.510.510.510.6
Borrowings0.60.42.20.115.227.125.929.9
└ Current0.40.32.20.115.227.125.929.9
└ Non-current0.30.10.10.00.00.00.00.0
Trade payables78.687.7107.2131.5187.9167.2192.9238.5
Current liabilities106.7121.2148.7171.8270.9249.4273.3320.9
Total liabilities109.9126.7153.9176.3275.7254.7280.1326.5
Net debt(178.8)(131.5)(166.4)(204.3)(197.9)(212.2)(234.7)(240.3)
Debt / equity0.000.000.010.000.030.050.050.05
Current ratio3.792.922.612.511.912.112.061.95

Cash flow, year to date

 H1 FY23FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26
Operating cash flow20.961.053.7109.029.768.255.9104.9
└ Capex(11.2)(70.9)(15.6)(37.7)(31.1)(52.2)0.0(67.7)
Free cash flow9.7(9.9)38.171.3(1.5)16.055.937.3
Investing cash flow15.5(14.1)(44.5)(92.1)(37.4)(74.1)(43.8)(91.8)
Financing cash flow(15.1)(43.7)(11.8)(15.3)2.81.0(12.4)(13.0)
└ Dividends paid(7.6)(7.6)(8.3)(8.3)0.0(11.5)(12.2)(12.2)
└ Buybacks0.00.0(4.0)0.00.00.00.00.0
Net change in cash21.33.1(2.5)1.6(4.9)(4.9)(0.2)0.1

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

WINDLAS at a glance

  • WINDLAS closed at ₹961.25 on 20 Nov 2026, -2.16% on the day, +17.1% over one year, 18.7% below its 52-week high of ₹1,181.9.
  • Delivery was 57.6% of traded quantity on 20 Nov 2026, the 66th percentile of its own 1,302 sessions with a reading (20-session average 50.1%, 1-year average 53.9%).
  • Market capitalisation is ₹1,984 crore at a trailing P/E of 29.8 (trailing EPS ₹32.31).
  • Q4 FY26 results (consolidated, filed 21 May 2026): revenue ₹238 crore (+17.7% year on year), net profit ₹16 crore (-1.8%); the price moved +1.0% on the first session after.
  • Promoters held 63.31% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 3 Feb 2027 and 11 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryPharmaceuticals
ISININE0H5O01029
SeriesEQ
Listed16 Aug 2021
IPO price460.00 · band Rs.448 to Rs.460
IPO listing16 Aug 2021
NSE market cap · 17 Nov 2026₹2,068 Cr
Free-float market cap (NSE)₹753 Cr
Shares outstanding (NSE)2.06Cr
History from16 Aug 2021
Sessions1,306
Turnover rank#854

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.